Septerna (SEPN) Income from Continuing Operations (2023 - 2026)
Septerna's (SEPN) quarterly Income from Continuing Operations came in at 8637000.0 in Q1 2026, up 59.78% year-on-year from 5405455.69 in Q1 2025, and up 19.57% quarter-over-quarter from 10738000.0 in Q4 2025.
Septerna (SEPN) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Septerna's Income from Continuing Operations history runs 4 years deep, the most recent figure standing at 8637000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 59.78% year-over-year to 8637000.0 in Q1 2026; TTM through Mar 2026 was 36040000.0, a 54.57% increase from a year earlier, with the FY2025 full-year figure at 48879000.0, up 31.92% from the prior year.
- Income from Continuing Operations grew to 8637000.0 in Q1 2026 per SEPN's latest filing, from 10738000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 8173000.0 in Q3 2025 and bottomed at 24838000.0 in Q2 2025.
- The 4-year median for Income from Continuing Operations is 16659000.0 (2024), against an average of 14437818.18.
- Across the five-year window, Income from Continuing Operations sank 87.51% in 2024 and surged 139.82% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 18153000.0 in 2023, then slipped by 13.85% to 20668000.0 in 2024, then jumped by 48.05% to 10738000.0 in 2025, then rose by 19.57% to 8637000.0 in 2026.
- Per Business Quant, the three latest SEPN Income from Continuing Operations figures stand at 8637000.0 (Q1 2026), 10738000.0 (Q4 2025), and 8173000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | -8.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.64 Mn |
| Dec 31, 2025 | -10.74 Mn |
| Sep 30, 2025 | 8.17 Mn |
| Jun 30, 2025 | -24.84 Mn |
| Mar 31, 2025 | -21.48 Mn |
| Dec 31, 2024 | -20.67 Mn |
| Sep 30, 2024 | -20.52 Mn |
| Jun 30, 2024 | -16.66 Mn |
| Mar 31, 2024 | -14.35 Mn |
| Dec 31, 2023 | -18.15 Mn |
| Sep 30, 2023 | -10.95 Mn |